Pfizer's Russian effect sends arthritis drug back to Ablynx to confirm 8-week dosing
04 November 2011
John Hodgson
Please Login to read the full article.
04 November 2011
John Hodgson
Please Login to read the full article.
RELATED CONTENT
NEWS
- UCB execs take positive stance as big pharma peers wail about difficult environment
- Pharmos seeks gout bandwagon partner in last-chance saloon
- Enbrel sales force consolidated under Amgen as approval nears for Pfizer RA drug
- US FDA panel: Let anti-NGF studies move forward, despite 'severe' joint risks
ANALYSIS
Other Informa Analysis
COMMENT
Other Informa Comment
EVENTS
Today
The Rembrandt Hotel, London
07 June 2012
The Rembrandt Hotel, London
12 June 2012
Annecy, France
JOB OF THE WEEK
Section Head (m/f)
DRA International/CIS Section
Section Head (m/f)
DRA International/CIS Section
